XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profile Mescaline is illegal under U.S. federal law, but some...
While more research is needed, a recent study provides some evidence that using CBD to transition from tobacco addiction holds significant promise Supply chain issues are the main barrier to entry to the CBD cigarette industry for big tobacco GRYN already owns the...
An ultra-premium cannabis grower for the medicinal and recreational cannabis markets in California, Sonoma Biologics Corp. is committed to using only organic-equivalent outdoor growing techniques to cultivate its cannabis product at a fraction of the cost of its...
PULL signs Letter of Intent with Psyence Group to co-develop extraction techniques for production of psilocybin drug formulations Psyence is one of world’s first psychedelic mushroom companies operating a federally legal commercial cultivation and extraction facility...
Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partner XPhyto received approval for the test kit last month from European...
Company announces flagship product name, logo now protected intellectual property rights “Securing our trade name is another step forward in the dawning of the Hourglass era,” says CEO Grapefruit intends to apply for similar trademark protection when the federal...
